[Federal Register Volume 75, Number 66 (Wednesday, April 7, 2010)]
[Notices]
[Pages 17769-17770]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-7829]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-679]


In the Matter of Certain Products Advertised as Containing 
Creatine Ethyl Ester; Notice of Commission Issuance of a Limited 
Exclusion Order Against the Products Advertised as Containing Creatine 
Ethyl Ester of Respondents Found in Default; Issuance of Cease and 
Desist Orders

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has issued a limited exclusion order and cease and desist 
orders against four respondents found in default in the above-captioned 
investigation under section 337 of the Tariff Act of 1930, as amended, 
19 U.S.C. 1337.

FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street, SW., 
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street, SW., Washington, DC 
20436, telephone (202) 205-2000. General information concerning the 
Commission may also be obtained by accessing its Internet server 
(http://www.usitc.gov). The public record for this investigation may be 
viewed on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. Hearing-impaired persons are advised that information 
on this matter can be obtained by contacting the Commission's TDD 
terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: This investigation was instituted on June 
23, 2009, based upon a complaint filed on behalf of UneMed Corp. of 
Omaha, Nebraska (``UneMed'') on June 5, 2009, and supplemented on June 
8 and 10, 2009. 74 FR 29717 (June 23, 2009). The complaint alleged 
violations of section 337(a)(1)(A) of the Tariff Act of 1930 (19 U.S.C. 
1337) in the importation into the United States, the sale for 
importation, and the sale within the United States after importation of 
certain products advertised as containing creatine ethyl ester by 
reason of false advertising in violation of Section 43(a) of the Lanham 
Act, 15 U.S.C. 1125(a)(1)(B) and the

[[Page 17770]]

Nebraska Uniform Deceptive Trade Practices Act, R.R.S. Neb. Sec.  87-
302 (2008). The complaint named as respondents Bodyonics, Ltd. of 
Hicksville, New York (``Bodyonics''); EST Nutrition LLC d/b/a 
Engineered Sport Technology, Inc. of Oviedo, Florida (``EST''); 
Proviant Technologies, Inc. of Champagne, Illinois (``Proviant''); NRG-
X Labs. of Bentonville, Arkansas (``NRG-X''); and San Corporation of 
Oxnard, California.
    On September 29, 2009, the Commission issued notice of its decision 
not to review an ID terminating the investigation with respect to San 
Corporation on the basis of a consent order.
    On October 19, 2009, the Commission issued notice of its 
determination not to review an ID finding Bodyonics, NRG-X, and 
Proviant in default. On December 23, 2009, the Commission issued notice 
of its determination not to review an ID finding respondent EST in 
default, and requesting briefing on remedy, the public interest, and 
bonding with respect to the respondents found in default. 74 FR 69146 
(Dec. 30, 2009).
    On January 6, 2010, UneMed submitted briefing, requesting a limited 
exclusion order, cease and desist orders, and bonding at the level of 
100 percent of entered value during the period of Presidential review. 
Also on January 6, 2010, the Commission investigative attorney (IA) 
submitted briefing, proposing the same.
    The Commission found that each of the statutory requirements of 
section 337(g)(1)(A)-(E), 19 U.S.C. 1337(g)(1)(A)-(E), has been met 
with respect to the defaulting respondents. Accordingly, pursuant to 
section 337(g)(1), 19 U.S.C. 1337(g)(1), and Commission rule 210.16(c), 
19 CFR 210.16(c), the Commission presumed the facts alleged in the 
complaint to be true.
    The Commission determined that the appropriate form of relief in 
this investigation includes a limited exclusion order prohibiting the 
unlicensed entry of certain products advertised as containing creatine 
ethyl ester by reason of false advertising in violation of Section 
43(a) of the Lanham Act, 15 U.S.C. 1125(a)(1)(B) and the Nebraska 
Uniform Deceptive Trade Practices Act, R.R.S. Neb. Sec.  87-302 (2008). 
The order covers certain products advertised as containing creatine 
ethyl ester that are manufactured abroad by or on behalf of, or 
imported by or on behalf of, respondents Bodyonics, EST, Proviant, or 
NRG-X, or any of their affiliated companies, parents, subsidiaries, or 
other related business entities, or their successors or assigns. The 
Commission also determined to issue cease and desist orders prohibiting 
domestic respondents Bodyonics, EST, Proviant, or NRG-X from importing, 
selling, marketing, advertising, distributing, offering for sale, 
transferring (except for exportation), and soliciting U.S. agents or 
distributors for certain products advertised as containing creatine 
ethyl ester. The Commission further determined that the public interest 
factors enumerated in section 337(g)(1), 19 U.S.C. 1337(g)(1), do not 
preclude issuance of the limited exclusion order and cease and desist 
orders. Finally, the Commission determined that the bond under the 
limited exclusion order during the period of Presidential review shall 
be in the amount of 100 percent of the entered value of the imported 
articles. The Commission's orders were delivered to the President and 
the United States Trade Representative on the day of their issuance.
    The Commission has therefore terminated this investigation. The 
authority for the Commission's determination is contained in section 
337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
sections 210.16(c) and 210.41 of the Commission's Rules of Practice and 
Procedure (19 CFR 210.16(c) and Sec.  210.41).

    Issued: April 1, 2010.

    By order of the Commission.
William R. Bishop,
Acting Secretary to the Commission.
[FR Doc. 2010-7829 Filed 4-6-10; 8:45 am]
BILLING CODE P